Sulfonylurea use before stroke does not influence outcome

Christopher G. Favilla, Michael T. Mullen, Myzoon Ali, Peter Higgins, Scott E. Kasner

    Research output: Contribution to journalArticlepeer-review

    31 Citations (Scopus)


    Sulfonylureas block nonselective cation channels and lower serum glucose and are neuroprotective in animal models of ischemic stroke. Human data on sulfonylureas in acute stroke are sparse and conflicting. We aimed to measure the potential neuroprotective effect of prestroke sulfonylurea use in diabetic patients. We analyzed data from a prospective cohort of individuals with diabetes mellitus (DM) enrolled in nonreperfusion ischemic stroke trials within Virtual International Stroke Trials Archive (VISTA) comprising 1050 patients, 298 with sulfonylurea use before stroke onset. The primary outcome measures were baseline National Institutes of Health Stroke Scale score and 90-day modified Rankin Scale score.

    Original languageEnglish
    Pages (from-to)710-715
    Number of pages6
    Issue number3
    Publication statusPublished - 1 Feb 2011


    • stroke
    • diabetes mellitus
    • sulfonylurea
    • neuroprotection


    Dive into the research topics of 'Sulfonylurea use before stroke does not influence outcome'. Together they form a unique fingerprint.

    Cite this